PharmaDossierIndependent biopharma information, guidance, and source-cited analysis.
Topic

DOAC

Direct oral anticoagulants, factor Xa inhibitors, apixaban, rivaroxaban, edoxaban, dabigatran, formulary, and access.

1 article·Lives underPricing & AccessPolicy·Last updated